These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 9987734

  • 1. GnRH agonist. Increasing the pregnancy rate after combined treatment with hMG/hCG and direct intraperitoneal insemination.
    Minoura H, Takeuchi S, Shen X, Shibahara T, Futamura N, Toyoda N.
    J Reprod Med; 1999 Jan; 44(1):18-22. PubMed ID: 9987734
    [Abstract] [Full Text] [Related]

  • 2. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
    Costello MF, Hughes GJ, Garrett DK, Hanjani A, Steigrad SJ.
    Int J Fertil Womens Med; 1998 Jan; 43(1):28-33. PubMed ID: 9532467
    [Abstract] [Full Text] [Related]

  • 3. [Controlled hyperstimulation in intra-uterine inseminations: hMG-hCG protocol (204 cycles)].
    Abboud P, Delépine B, Pigeon F, Bednarczyk L, Quéreux C.
    Contracept Fertil Sex; 1997 Jun; 25(6):463-9. PubMed ID: 9280551
    [Abstract] [Full Text] [Related]

  • 4. [Application of ultra-short gonadotropin-releasing hormone agonist protocol in controlled ovarian hyperstimulation].
    Zhao X, Zhang L, Gong S.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Oct; 32(10):589-92. PubMed ID: 9642373
    [Abstract] [Full Text] [Related]

  • 5. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
    Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Grøndahl ML, Westergaard L, Andersen CY.
    Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
    [Abstract] [Full Text] [Related]

  • 6. Superovulation and intrauterine insemination vs. superovulation alone in the treatment of unexplained infertility. A randomized study.
    Arcaini L, Bianchi S, Baglioni A, Marchini M, Tozzi L, Fedele L.
    J Reprod Med; 1996 Aug; 41(8):614-8. PubMed ID: 8866392
    [Abstract] [Full Text] [Related]

  • 7. Treating infertility. Controlled ovarian hyperstimulation using human menopausal gonadotropin in combination with intrauterine insemination.
    Vollenhoven B, Selub M, Davidson O, Lefkow H, Henault M, Serpa N, Hung TT.
    J Reprod Med; 1996 Sep; 41(9):658-64. PubMed ID: 8887190
    [Abstract] [Full Text] [Related]

  • 8. A novel, simplified and cost effective protocol for superovulation and intrauterine insemination.
    Williams RS, Kipersztok S, Hills D, Dattilo M.
    J Fla Med Assoc; 1997 Sep; 84(5):316-9. PubMed ID: 9260436
    [Abstract] [Full Text] [Related]

  • 9. Cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination. Influence of the number of mature follicles at hCG administration.
    Kaplan PF, Katz SL, Thompson AK, Freund RD.
    J Reprod Med; 2002 Jul; 47(7):535-9. PubMed ID: 12170528
    [Abstract] [Full Text] [Related]

  • 10. No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women with unexplained infertility after controlled ovarian hyperstimulation and intrauterine insemination.
    Werbrouck E, Spiessens C, Meuleman C, D'Hooghe T.
    Fertil Steril; 2006 Sep; 86(3):566-71. PubMed ID: 16952506
    [Abstract] [Full Text] [Related]

  • 11. Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination.
    Duffy DA, Manzi D, Benadiva C, Maier D, Saunders M, Nulsen J.
    Fertil Steril; 2006 Feb; 85(2):407-11. PubMed ID: 16595219
    [Abstract] [Full Text] [Related]

  • 12. The efficacy of nafarelin acetate versus leuprolide acetate in conjunction with human menopausal gonadotropins for superovulation/intrauterine insemination.
    Schmidt-Sarosi CL, Yerovi LA.
    Int J Fertil Menopausal Stud; 1994 Feb; 39(1):20-5. PubMed ID: 8167676
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Does the addition of a gonadotropin-releasing hormone agonist improve the pregnancy rate in intrauterine insemination? A prospective controlled trial.
    Eskandar MA.
    Gynecol Endocrinol; 2007 Oct; 23(10):551-5. PubMed ID: 17891598
    [Abstract] [Full Text] [Related]

  • 16. Addition of gonadotrophin-releasing hormone agonist and/or two inseminations with husband's sperm do not improve the pregnancy rate in superovulated cycles.
    Karlström PO, Bergh T, Lundkvist O.
    Acta Obstet Gynecol Scand; 2000 Jan; 79(1):37-42. PubMed ID: 10646814
    [Abstract] [Full Text] [Related]

  • 17. A randomized and longitudinal study of human menopausal gonadotropin with intrauterine insemination in the treatment of infertility.
    Nulsen JC, Walsh S, Dumez S, Metzger DA.
    Obstet Gynecol; 1993 Nov; 82(5):780-6. PubMed ID: 8414326
    [Abstract] [Full Text] [Related]

  • 18. Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study.
    Kocak M, Dilbaz B, Demir B, Taşci Y, Tarcan A, Dede S, Haberal A.
    Gynecol Endocrinol; 2010 Jun; 26(6):429-34. PubMed ID: 20175705
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study.
    Demirol A, Gurgan T.
    Hum Reprod; 2007 Jan; 22(1):97-100. PubMed ID: 16954409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.